OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Opinion on Drug Delivery is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatmen	66
Artificial Intelligence’s role in colon-targeted drug delivery	64
All eyes on semifluorinated alkanes: a comprehensive review of the influence of semifluorinated alkane eyedrops on tear film stabilization and drug delivery in dry eye disease	58
A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement	54
Calcium phosphate coated nanoparticles for drug delivery: where are we now?	52
Iontophoresis for the cutaneous delivery of nanoentraped drugs	51
Brain delivery enabled by transient blood–brain barrier disruption induced by regadenoson: a PET imaging study	51
In vivo dermal delivery of bleomycin with electronic pneumatic injection: drug visualization and quantification with mass spectrometry	51
How can nanoemulsions be used for photosensitizer drug delivery?	50
Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part II: polymeric nanocarriers f	50
Challenges and opportunities in neurometabolic disease treatment with enzyme delivery	48
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges	45
The quest to deliver high-dose rifampicin: can the inhaled approach help?	45
Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study	43
Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years	41
Current insights into polymeric micelles for nasal drug delivery	40
Nanominerals: a multifaceted biomaterial for regenerative medicine and drug delivery	38
Self-assembled structures of ascorbic acid derivatives: encapsulation properties and controlled drug delivery applications	38
The challenges of drug delivery to the esophagus and how to overcome them	37
Nuclear medicine imaging methods as novel tools in the assessment of pulmonary drug disposition	37
Pre-ANDA strategy and Human Factors activities to de-risk pharmaceutical companies ANDA submission of drug–device combination products: case study of a formative Comparative Use Human Factors study	37
Hydrophobic ion pairing-based self-emulsifying drug delivery systems: a new strategy for improving the therapeutic efficacy of water-soluble drugs	36
Enhanced skin drug delivery using dissolving microneedles: a potential approach for the management of skin disorders	35
Acetalated dextran: a novel delivery platform for particle-based vaccines	34
Magnetoliposomes for nanomedicine: synthesis, characterization, and applications in drug, gene, and peptide delivery	34

Innovative insight into the mechanism of enantioselective skin permeation for chiral drugs	34
Future applications of self-immolative polymers in drug delivery	33
Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms	32
Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors - a comprehensive review	32
Nanoemulsion-based dosage forms for the transdermal drug delivery applications: A review of recent advances	30
Current status and prospect for future advancements of long-acting antibody formulations	30
An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery	30
Novel formulations of metal-organic frameworks for controlled drug delivery	30